Absci Investor Presentation Deck

Well positioned to revolutionize Al drug creation absci ABSCI CORPORATION 2023 ALL RIGHTS RESERVED inimit unan't T >160 77,000+ Square Feet ~$450M NASDAQ Listed Unlimiters with deep experience in Al, immunology, synthetic biology, and protein expression. Leading Al team with expertise from: OpenAI Meta l'lii HARVARD Google TESLA UNIVERSITY VE RO TAS State-of-the-art drug creation and wet lab space in Vancouver WA, Absci Al Research (AAIR) lab in NYC, and the Innovation Centre in Zug Switzerland Capital raised to date $ABSI IPO July 22, 2021, ten years after founding in a basement lab absci. 43

View entire presentation